NEOGENOMICS INC|4Feb 25, 4:41 PM ET

Aunan Greg D 4

4 · NEOGENOMICS INC · Filed Feb 25, 2025

Form 4

Period: 2025-02-21

Chief Accounting Officer

Transactions

Award
Stock Option (Right to Buy)
2025-02-21+31,163→ 31,163 total
Exercise: $11.86Exp: 2035-02-21→ Common Stock (31,163 underlying)
Award
Restricted Stock Unit
2025-02-21+18,971→ 18,971 total
Exercise: $0.00→ Common Stock (18,971 underlying)

Holdings

Stock Option (Right to Buy)
Exercise: $14.62Exp: 2030-05-01→ Common Stock (28,662 underlying)
28,662
Common Stock
14,453
Stock Option (Right to Buy)
Exercise: $13.96Exp: 2034-05-02→ Common Stock (26,978 underlying)
26,978
Restricted Stock Unit
Exercise: $0.00→ Common Stock (16,117 underlying)
16,117

Footnotes (6)

[F1]On February 21, 2025, Mr. Aunan was granted 31,163 stock options. These options vest ratably over the first three anniversary dates of the grant date.
[F2]On February 21, 2025, Mr. Aunan was granted 18,971 restricted stock units. These restricted stock units vest ratably over the first three anniversary dates of the grant date.
[F3]Once vested, the shares of common stock are not subject to expiration.
[F4]On May 1, 2023, Mr. Aunan was granted 28,662 stock options. These options vest ratably over the first four anniversary dates of the grant date.
[F5]On May 2, 2024, Mr. Aunan was granted 26,978 stock options. These options vest ratably over the first three anniversary dates of the grant date.
[F6]On May 2, 2024, Mr. Aunan was granted 16,117 restricted stock units. These restricted stock units vest ratably over the first three anniversary dates of the grant date.

Documents

1 file